Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue
Authors:
- András FehérAFAndrás Fehér
- Hartwig WolburgHWHartwig Wolburg
- Péter SiposPSPéter Sipos
- Szilvia VeszelkaSzilvia Veszelka
- Andrea TóthATAndrea Tóth
- Lóránd KisLKLóránd Kis
- Anita KuruncziAKAnita Kurunczi
- Gábor BaloghGBGábor Balogh
- Levente KürtiLKLevente Kürti
- István ErősIEIstván Erős
- Piroska Szabó-RévészPSPiroska Szabó-Révész
- 1 May 2009
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 72 (1) , 252-259
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and PharmacologyCellular and Molecular Neurobiology, 2005
- Drug transport to brain with targeted liposomesNeuroRX, 2005
- Development of neuropeptide drugs that cross the blood-brain barrierNeuroRX, 2005
- The blood-brain barrier: Bottleneck in brain drug developmentNeuroRX, 2005
- Nasal drug delivery—possibilities, problems and solutionsJournal of Controlled Release, 2003
- Nasal drug delivery: new developments and strategiesDrug Discovery Today, 2002
- Transport of drugs from the nasal cavity to the central nervous systemEuropean Journal of Pharmaceutical Sciences, 2000
- Brain drug delivery technologies: novel approaches for transporting therapeuticsPharmaceutical Science & Technology Today, 2000
- Targeted drug delivery to the brain via phosphonate derivatives: I. Design, synthesis and evaluation of an anionic chemical delivery system for testosteroneInternational Journal of Pharmaceutics, 1998
- Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery.Journal of Clinical Investigation, 1979